对TRPA1抗剂的更新专利审查 (2020年至今)
Rosa Maria Vitale, Luciano de Petrocellis1, Pietro Amodeo
1Institute of Biomolecular Chemistry (ICB), National Research Council of Italy (CNR), Pozzuoli (NA), Italy.
最近的专利揭示了TRPA1抗剂的新应用. 研究强调TRPA1在疼痛,和炎症中的作用,扩大了阿尔茨海默氏症等疾病的治疗点.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 药用化学 医学化学
背景情况:
- TRPA1 (过渡受体潜在氨酸1) 是一种通道,由刺激物激活,调解疼痛,和炎症.
- TRPA1是治疗疼痛,和炎症性呼吸道疾病的治疗点.
研究的目的:
- 从2020年到现在,对TRPA1抗剂的审查专利.
- 将对抗剂分类为新型应用,自然来源和新型化合物.
- 强调人们对TRPA1作为治疗点的兴趣日益增长.
主要方法:
- 专利文献搜索 (2020年至今).
- TRPA1抗剂的分类.TRPA1抗剂的分类.
- 对TRPA1的生理病理作用进行基础研究的综述.
主要成果:
- 专利涵盖已知的对抗剂的新疗法用途.
- 从自然来源发现的新型TRPA1抗剂.
- 新型TRPA1抗化合物的合成和评估.
结论:
- TRPA1对抗剂在治疗疼痛,和炎症状况方面表现有前途.
- 新兴研究表明TRPA1与阿尔茨海默氏症和眼部疾病有关.
- 对用于各种治疗应用的TRPA1调节器的持续兴趣.
更多相关视频
12:09Yeast Luminometric and Xenopus Oocyte Electrophysiological Examinations of the Molecular Mechanosensitivity of TRPV4
Published on: December 31, 2013
10:20Method for Identifying Small Molecule Inhibitors of the Protein-protein Interaction Between HCN1 and TRIP8b
Published on: November 11, 2016
相关概念视频
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Antipsychotic Drugs: Typical and Atypical Agents
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
